Herantis Pharma's Annual Report 2014 published
Herantis Pharma Plc Company release 24 March 2015 at 10:00 am Herantis Pharma Plc's Annual Report for the year 2014 has been published today. The Annual Report contains financial statements and the report of the Board of Directors. The Annual Report is available in PDF format in Finnish and English as an appendix to this release and on the company's web site at https://herantis.com in section Investors - Financial information. Further information: Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445 Company web site: www.herantis.com Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225 About Herantis Pharma Plc Herantis Pharma Plc is a pharmaceutical company specialised in new drug research and development. The company focuses on diseases with an unmet clinical need. These diseases include for example dry eye syndrome, Parkinson's disease, and secondary lymphedema. We believe our drugs are the first or best in their class and have the potential to change treatment strategies of diseases. The shares of Herantis Pharma Plc are listed on the First North Finland marketplace run by NASDAQ Helsinki stock exchange.